These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 7831373

  • 1. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
    Elsbach P, Weiss J, Doerfler M, Shu C, Kohn F, Ammons WS, Kung AH, Meszaros KK, Parent JB.
    Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
    [Abstract] [Full Text] [Related]

  • 2. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide.
    Elsbach P, Weiss J.
    Immunobiology; 1993 Apr; 187(3-5):417-29. PubMed ID: 8330906
    [Abstract] [Full Text] [Related]

  • 3. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin.
    Elsbach P.
    Ciba Found Symp; 1994 Apr; 186():176-87; discussion 187-9. PubMed ID: 7768151
    [Abstract] [Full Text] [Related]

  • 4. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O, Ooi CE, Elsbach P, Doerfler ME, Lehrer RI, Weiss J.
    J Immunol; 1995 May 15; 154(10):5403-10. PubMed ID: 7730641
    [Abstract] [Full Text] [Related]

  • 5. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
    Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW.
    J Immunol; 1990 Jan 15; 144(2):662-6. PubMed ID: 2295804
    [Abstract] [Full Text] [Related]

  • 6. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE, Weiss J, Doerfler ME, Elsbach P.
    J Exp Med; 1991 Sep 01; 174(3):649-55. PubMed ID: 1875165
    [Abstract] [Full Text] [Related]

  • 7. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
    Capodici C, Chen S, Sidorczyk Z, Elsbach P, Weiss J.
    Infect Immun; 1994 Jan 01; 62(1):259-65. PubMed ID: 8262637
    [Abstract] [Full Text] [Related]

  • 8. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J, Elsbach P, Shu C, Castillo J, Grinna L, Horwitz A, Theofan G.
    J Clin Invest; 1992 Sep 01; 90(3):1122-30. PubMed ID: 1522221
    [Abstract] [Full Text] [Related]

  • 9. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A, McKinney CE, Rinaldi M, Zarlenga DS, Bannerman DD.
    Vet Microbiol; 2007 Nov 15; 125(1-2):80-90. PubMed ID: 17560054
    [Abstract] [Full Text] [Related]

  • 10. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
    Weersink AJ, van Kessel KP, van den Tol ME, van Strijp JA, Torensma R, Verhoef J, Elsbach P, Weiss J.
    J Immunol; 1993 Jan 01; 150(1):253-63. PubMed ID: 7678030
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW.
    J Immunol; 1992 Jan 15; 148(2):532-7. PubMed ID: 1729370
    [Abstract] [Full Text] [Related]

  • 13. Prospects for use of recombinant BPI in the treatment of gram-negative bacterial infections.
    Elsbach P, Weiss J.
    Infect Agents Dis; 1995 Jun 15; 4(2):102-9. PubMed ID: 7613727
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
    Levy O, Sisson RB, Kenyon J, Eichenwald E, Macone AB, Goldmann D.
    Infect Immun; 2000 Sep 15; 68(9):5120-5. PubMed ID: 10948134
    [Abstract] [Full Text] [Related]

  • 15. [A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin].
    Zhou H.
    Zhonghua Shao Shang Za Zhi; 2001 Apr 15; 17(2):102-4. PubMed ID: 11876922
    [Abstract] [Full Text] [Related]

  • 16. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J, Muello K, Victor M, Elsbach P.
    J Immunol; 1984 Jun 15; 132(6):3109-15. PubMed ID: 6373924
    [Abstract] [Full Text] [Related]

  • 17. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS, Acton RD, Battafarano RJ, Uknis ME, Ratz CA, Johnston JW, Haseman JR, Gray BH, Dunn DL.
    J Surg Res; 1996 Jun 15; 63(1):44-8. PubMed ID: 8661170
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
    Rauniyar RK, Suzuma K, King AL, Aiello LP, King GL.
    Invest Ophthalmol Vis Sci; 2002 Feb 15; 43(2):503-9. PubMed ID: 11818397
    [Abstract] [Full Text] [Related]

  • 19. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z, Hong Z, Guo W, Xiaoyun G, Gengfa L, Yongning L, Guangxia X.
    Int Immunopharmacol; 2004 Apr 15; 4(4):527-37. PubMed ID: 15099530
    [Abstract] [Full Text] [Related]

  • 20. Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function.
    Capodici C, Weiss J.
    J Immunol; 1996 Jun 15; 156(12):4789-96. PubMed ID: 8648126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.